Pulmonary Hypertension

About Pulmonary Hypertension

Echocardiographic probability of Pulmonary Hypertension (first algorithm) and Monitoring of patients after Pulmonary Embolism (second algorithm), aiming at the early diagnosis of Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

The echocardiographic probability of the presence of pulmonary hypertension is based on an analysis of parameters during an echocardiogram (cardiac triplex), should be investigated and recorded in each echocardiographic study finding, and is distinguished as low, moderate or high. The echocardiographic possibility and risk factors for the manifestation of pulmonary hypertension are key steps in the diagnosis of pulmonary arterial hypertension, which is established after right heart catheterization and thorough control, in special centers of pulmonary hypertension. The first algorithm includes the above steps and has the goal of highlighting the echocardiographic possibility in a patient with symptomatic or suspected pulmonary hypertension and the appropriate way of management, according to the guidelines of the European Society of Cardiology.

Follow-up of patients 3-6 months after pulmonary embolism under appropriate anticoagulation is necessary with the aim of identifying those with thromboembolic disease and early diagnosis of chronic thromboembolic pulmonary hypertension. The echocardiographic possibility of pulmonary hypertension (first algorithm) has a primary role in the follow-up of these patients, as well as imaging and biochemical tests. The second algorithm includes the steps in the follow-up of patients with pulmonary embolism, indicated according to the guidelines of the European Society of Cardiology, with the aim of early diagnosis of chronic thromboembolic pulmonary hypertension, which is established after a complete imaging and hemodynamic control (right heart catheterization) in a special pulmonary hypertension center.

This application is intended to serve as an auxiliary tool for specialized cardiologists in the field of Pulmonary Hypertension, and in no way can replace advice and monitoring from a real cardiologist.